GT199700037A - Composiciones farmaceuticas para el tratamiento de la rinitis - Google Patents

Composiciones farmaceuticas para el tratamiento de la rinitis

Info

Publication number
GT199700037A
GT199700037A GT199700037A GT199700037A GT199700037A GT 199700037 A GT199700037 A GT 199700037A GT 199700037 A GT199700037 A GT 199700037A GT 199700037 A GT199700037 A GT 199700037A GT 199700037 A GT199700037 A GT 199700037A
Authority
GT
Guatemala
Prior art keywords
rhinitis
treatment
pharmaceutical compositions
individual
pseudoefedrina
Prior art date
Application number
GT199700037A
Other languages
English (en)
Inventor
De Venne Herman Van
Jean-Pierre Martin
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24521774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199700037(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of GT199700037A publication Critical patent/GT199700037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA CANTIDAD TERAPEUTICAMENTE EFICAZ DE UNA MEZCLA CONSISTENTE ESENCIALMENTE EN : I) COMPUESTO SELECCIONADO DE PSEUDOEFEDRINA, FENILPROPANOLAMINA Y FENILEFRINA, UN ISOMERO OPTICO INDIVIDUAL O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LA MISMA, Y II) AL MENOS UN COMPUESTO SELECCIONADO DEL ACIDO 2[4(DIFENILMETIL)1PIPERACINIL]ACETICO O DERIVADO AMIDICOS, UN ISOMERO OPTICO INDIVIDUAL O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO.
GT199700037A 1996-04-08 1997-04-04 Composiciones farmaceuticas para el tratamiento de la rinitis GT199700037A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/629,144 US6469009B1 (en) 1996-04-08 1996-04-08 Pharmaceutical compositions for the treatment of rhinitis

Publications (1)

Publication Number Publication Date
GT199700037A true GT199700037A (es) 1998-09-26

Family

ID=24521774

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199700037A GT199700037A (es) 1996-04-08 1997-04-04 Composiciones farmaceuticas para el tratamiento de la rinitis

Country Status (10)

Country Link
US (2) US6469009B1 (es)
AU (1) AU723364B2 (es)
BR (1) BR9701686A (es)
CO (1) CO4820432A1 (es)
GB (1) GB2311940B (es)
GT (1) GT199700037A (es)
NZ (1) NZ314521A (es)
PA (1) PA8426801A1 (es)
PE (1) PE42598A1 (es)
SV (1) SV1997000026A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US6432961B1 (en) 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
US6651816B2 (en) * 2001-05-04 2003-11-25 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
US7014867B2 (en) * 2001-06-28 2006-03-21 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
US7403981B2 (en) * 2002-01-04 2008-07-22 Quicksilver Technology, Inc. Apparatus and method for adaptive multimedia reception and transmission in communication environments
AU2003220202A1 (en) * 2002-03-13 2003-09-29 Array Biopharma, Inc N3 alkylated benzimidazole derivatives as mek inhibitors
US20040132743A1 (en) * 2002-06-21 2004-07-08 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories, Inc. Amorphous form of (-)-[2-[4-[(4-Chlorophenyl)-phenyl methyl]-1- piperazinyl] ethoxy] acetic acid dihydrochloride (levocetirizine dihydrochloride)
WO2004004728A1 (en) * 2002-07-02 2004-01-15 Ucb Farchim S.A. Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis
JP4303925B2 (ja) * 2002-08-19 2009-07-29 篠田プラズマ株式会社 金属酸化膜の形成方法及びガス放電管の２次電子放出膜形成方法
ATE402703T1 (de) * 2002-12-06 2008-08-15 Ucb Farchim Sa Tablette enthaltend efletirizin und pseudoephedrin
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US20100172984A1 (en) * 2006-06-06 2010-07-08 Bijay Kumar Padhi tablet dosage form comprising cetirizine and pseudoephedrine
KR101288781B1 (ko) 2006-06-28 2013-07-22 암젠 인크 글리신 수송자-1 억제제
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20090062305A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched cetirizine
US20090082364A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched levocedtirizine
CA2750196C (en) * 2009-01-05 2017-06-20 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
WO2010078542A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
WO2010078543A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing cetirizine pseudoephedrine, and naproxen containing a barrier layer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US4800162A (en) 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5057427A (en) 1988-04-07 1991-10-15 Sepracor, Inc. Method for resolution of stereoisomers
GB8827391D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
WO1991017746A1 (en) * 1990-05-21 1991-11-28 Norwich Eaton Pharmaceuticals, Inc. The use of phenylpropanolamine as a mucus secretagogue in the upper airways
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
EP0885611A3 (en) 1992-09-24 1999-01-07 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
AU4932093A (en) 1992-09-24 1994-04-12 Sepracor, Inc. Compositions for treating allergic disorders using (-) cetirizine
CA2146637C (en) 1992-10-09 2001-02-13 James Grigg Upson Pharmaceutical compositions and methods for treating cold symptoms
JPH08509725A (ja) 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
EP0719156A1 (en) 1993-09-07 1996-07-03 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
BR9701686A (pt) 1998-11-10
AU723364B2 (en) 2000-08-24
AU1774097A (en) 1997-10-16
PA8426801A1 (es) 2000-05-24
PE42598A1 (es) 1998-08-17
GB9706842D0 (en) 1997-05-21
GB2311940A (en) 1997-10-15
MX9702532A (es) 1998-06-30
US6469009B1 (en) 2002-10-22
CO4820432A1 (es) 1999-07-28
US6489329B2 (en) 2002-12-03
SV1997000026A (es) 1998-11-10
US20010020023A1 (en) 2001-09-06
GB2311940B (en) 2000-07-19
NZ314521A (en) 1999-09-29

Similar Documents

Publication Publication Date Title
GT199700037A (es) Composiciones farmaceuticas para el tratamiento de la rinitis
ATE306261T1 (de) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
FI960504A0 (fi) Menetelmä terapeuttisten yhdisteiden ja rasvahappojen muodostamien konjugaattien valmistamiseksi
ES2182079T3 (es) Composiciones farmaceuticas de liberacion sostenida que contienen un derivado de dibenzotiazepina.
BG104089A (en) Dolastatine 15 derivatives
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
DK0888323T3 (da) Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
DE69824313D1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
AU7270798A (en) Antithrombotic agents
GB9907571D0 (en) Compounds
AU9270498A (en) Tricyclic compounds, preparation method and said method intermediates, appl ication as medicines and pharmaceutical compositions containing same
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
EE04058B1 (et) Benso[c]kinolisiini derivaadid, nende valmistamine ja kasutamine 5a-reduktaasi inhibiitoritena
BR9611276A (pt) Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto
CO4930269A1 (es) Composiciones farmaceuticas
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
ES2172179T3 (es) Composiciones farmaceuticas de liberacion controlada que contienen tiagabina.
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
ES2170377T3 (es) Composicion que contiene quitosana.